Stryker Recalls Two Metal Hip Implants, Stops Global Production

Posted on July 9, 2012

Amid growing concerns that its Rejuvenate Modular and ABG II modular-neck hip stems may be prone to “fretting and/or corrosion at or about the modular-neck junction” which could cause pain, swelling, and tissue damage, orthopedic device maker, Stryker, has voluntarily recalled those devices and will not produce them anymore.

A recent report issued by New Jersey-based Stryker touted the benefits of the modular neck stems, but also conceded that “in rare cases” they may be subject to the same issues plaguing metal-on-metal hip implants.

The U.S. Food and Drug Administration (FDA) has listed numerous adverse event reports concerning the devices on its Manufacturer and User Facility Device Experience (MAUDE) database.

The company stated in a press release that while its modular-neck stem systems provided surgeons with options to correct hip biomechanics and a patient’s anatomy, the decision to voluntarily remove the devices from the market and to terminate global distribution came after continued post-market surveillance. They also said that the surveillance data “may be predictive of a trend.”

On its website, Stryker insists that although the risk is extremely low, patients who are experiencing pain and swelling should schedule a visit with their surgeons to discuss their symptoms.

If you or someone you love has experienced swelling, pain, difficulty walking, or any other serious side effect due to a recalled metal Stryker hip implant — or any other metal-on-metal hip replacement — the Florida defective hip implant attorneys at Farah & Farah are committed to helping you. Get in touch with us at (800) 533-3555 to find out what your legal options are today.

  • This field is for validation purposes and should be left unchanged.